Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.

GE Vernova, just over a year into its existence as an independently-traded public company, is riding the artificial ...

Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

Investing.com -- RBC Capital Markets has upgraded its ratings on both Sartorius AG (ETR: SATG) and Sartorius Stedim (EPA: ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the 11 best debt-free stocks to invest in right now. On July 2, Morgan ...

The company raised its full-year 2025 guidance for revenue, net income, and earnings per share. These 10 stocks could mint the next wave of millionaires › Medpace (NASDAQ:MEDP), a clinical contract ...

Stay updated with real-time stock market news, Sensex & Nifty movements, top gainers and losers, expert analysis, IPO updates ...

In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...